The government today said it is examining a proposal for setting up a venture capital fund to promote drug discovery in India.
"The department of pharamceutical is in the process of examining a proposal to set up a venture fund for promoting pharma discovery and innovation," Minister of State for Chemicals and Fertilisers Srikant Kumar Jena said in a written reply to the Lok Sabha.
He said that currently the National Institute of Public Finance and Policy is preparing details of the fund.
Earlier, the government had announced that it is planning to set up a Rs 10,000-crore venture capital (VC) fund for financing new drug discovery projects in the country.
The country spends about Rs 2,000 crore every year on Research & Development activities. While the government contributes Rs 500 crore to this, the rest comes from the private sector.
The proposed funding of Rs 10,000 crore, which includes substantial contribution from the private pharma industry under the public private partnership (PPP) model, is likely to bring about a favourable environment for drug innovation in the country and to make India a hub for new drug discoveries.
Last year, the Department of Pharmaceuticals had prepared a white paper on promoting research and development funding in the country, and submitted the proposal to the Prime Minister's Office for approval.
As per the proposal, the government intends to undertake pro-active steps on four fronts -- building infrastructure for talent and research, encouraging public-private partnerships in infrastructure development, providing financial incentives to encourage innovation, and shaping a favourable regulatory environment.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
